FDAnews Drug Daily Bulletin

SUPERGEN ANNOUNCES ACHIEVEMENT OF $20 MILLION DACOGEN INJECTION MILESTONE

May 30, 2006
A A

SuperGen, Inc. announced today that the first commercial shipment of Dacogen (decitabine) injection was released by MGI PHARMA, INC. to wholesale drug distributors earlier this week. Under the terms of its exclusive worldwide licensing agreement with MGI PHARMA, SuperGen has achieved the $20 million commercialization milestone. Additionally, SuperGen will earn a royalty on worldwide net sales starting at 20% and escalating to a maximum of 30%.

Yahoo News (http://biz.yahoo.com/prnews/060526/nyf011.html?.v=49)